LivaNova (LIVN) Total Debt Growth (3y) (2018 - 2026)
LivaNova (LIVN) Total Debt Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.85 Bn | 194.25 Bn | 7.27 Bn | 24.63% |
| 2 | Stryker | 129.75 Bn | 126.28 Bn | 4.50 Bn | 4.89% |
| 3 | Medtronic | 119.86 Bn | 110.64 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 74.04 Bn | 73.50 Bn | 3.85 Bn | 11.72% |
| 5 | Edwards Lifesciences | 52.51 Bn | 48.26 Bn | 1.35 Bn | 0.11% |
| 6 | Dexcom | 34.75 Bn | 32.81 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn | -0.47% |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | -1.01% |
| 9 | Steris | 23.26 Bn | 22.78 Bn | 684.20 Mn | -13.48% |
| 10 | LivaNova | 4.32 Bn | 3.81 Bn | 273.67 Mn | -21.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -21.43% |
| Mar 31, 2026 | -20.08% |
| Dec 31, 2025 | -7.68% |
| Sep 30, 2025 | -8.04% |
| Jun 30, 2025 | -2.60% |
| Mar 31, 2025 | 15.25% |
| Dec 31, 2024 | 14.76% |
| Sep 30, 2024 | 10.66% |
| Jun 30, 2024 | -1.94% |
| Mar 31, 2024 | -1.74% |
| Dec 31, 2023 | -3.10% |
| Sep 30, 2023 | -3.38% |
| Jun 30, 2023 | -3.64% |
| Mar 31, 2023 | 1.53% |
| Dec 31, 2022 | 17.04% |
| Sep 30, 2022 | 12.31% |
| Jun 30, 2022 | 30.00% |
| Mar 31, 2022 | 36.62% |
| Dec 31, 2021 | 40.46% |
| Sep 30, 2021 | 43.30% |